Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population

Diagn Microbiol Infect Dis. 2022 Oct;104(2):115770. doi: 10.1016/j.diagmicrobio.2022.115770. Epub 2022 Jul 16.

Abstract

Feasibility of home blood sample collection methods for the presence of SARS-CoV-2 antibodies from VA Million Veteran Program (MVP) participants was tested to determine COVID-19 infection or vaccination status. Participants (n = 312) were randomly assigned to self-collect blood specimens using the Neoteryx Mitra Clamshell (n = 136) or Tasso-SST (n = 176) and asked to rate their experience. Mitra tip blood was eluted and Tasso tubes were centrifuged. All samples were stored at -80 °C until tested with InBios SCoV-2 Detect™ IgG ELISA, BioRad Platelia SARS-CoV-2 Total Ab Assay, Abbott SARS-CoV-2 IgG and AdviseDx SARS-CoV-2 IgG II assays. Participants rated both devices equally. The Abbott assay had the highest sensitivity (87% Mitra, 98% Tasso-SST) for detecting known COVID infection and/or vaccination. The InBios assay with Tasso-SST had the best sensitivity (97%) and specificity (80%) for detecting known COVID-19 infection and/or vaccination. Veterans successfully collected their own specimens with no strong preference for either device.

Keywords: Antibody; COVID-19; Capillary blood collection; Million Veteran Program; Veterans.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Viral
  • COVID-19 Testing
  • COVID-19* / diagnosis
  • Humans
  • Immunoglobulin G
  • SARS-CoV-2
  • Sensitivity and Specificity
  • Serologic Tests / methods
  • Veterans*

Substances

  • Antibodies, Viral
  • Immunoglobulin G